FOR IMMEDIATE RELEASE Baltimore, MD — October 23, 2025 — SilcsBio, a leader in physics-based computational drug design, is proud to announce the launch of the SilcsBio Software - Covalent Suite, an innovative addition to its expanding portfolio of drug discovery solutions. Designed to accelerate the discovery of targeted covalent inhibitors (TCIs), the Covalent Suite empowers [...]